ARTICLE

FindCenter AddIcon

World-First Clinical Trial Explores Safety and Efficacy of DMT for Major Depression

By Ruairi J. Mackenzie — 2020

The world’s first clinical trial testing the efficacy of the psychedelic compound N,N-dimethyltryptamine (DMT) has won approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA).

Read on www.technologynetworks.com

FindCenter Post-Image

Psychedelic Therapy and Racial Trauma: Offering Clients a Deeper Experience of Healing

Like most people of color in the United States, psychotherapist and researcher Monnica Williams has experienced myriad forms of racism. Early in her career, understanding its effects on her mind and body motivated her to help clients address their own racial trauma in therapy.

FindCenter AddIcon
FindCenter Post-Image

How Researchers and Advocates of Color Are Forging Their Own Paths in Psychedelic-Assisted Therapy

We’re seeing an explosion of medical research into psychedelics. Psilocybin, or shrooms, to treat major depressive disorder. Ayahuasca, a psychotropic plant medicine from the Amazon, and ibogaine, a potent hallucinogen from Africa, to treat addiction. LSD for anxiety.

FindCenter AddIcon
FindCenter Post-Image

Study Finds Ketamine Can Help Patients Manage Depression and PTSD

Through this treatment plan, the patient was able to “reconceptualize her trauma” and “was able to move through difficult memories and emotions rather than letting them consume her,” explained U of O associate professor, Monnica Williams.

FindCenter AddIcon
FindCenter Post-Image

Who Will Benefit From Psychedelic Medicine?

These substances are being touted as a game-changing intervention for mental health. But it’s not clear if their promise will be accessible to all.

FindCenter AddIcon
FindCenter Post-Image

Psychedelics Shown to Ease the Effects of Racial Trauma

A recent study found that even a single positive psychedelic experience may ease mental health symptoms associated with racial trauma experienced by Black, Indigenous, and people of color (BIPOC).

FindCenter AddIcon
FindCenter Post-Image

What Ails Us

Most genetic studies completely ignore the science of epigenetics, which is how the environment actually turns certain genes on or off.

FindCenter AddIcon
FindCenter Post-Image

Psychedelics and Race: A Profile of Dr. Monnica T. Williams

The exuberant “renaissance” of studies researching psychedelic-assisted psychotherapy in the past twenty years has not sufficiently included the enrollment of racially diverse participants, a problem that psychedelic science and clinical research shares with mainstream psychiatry

FindCenter AddIcon
FindCenter Post-Image

Mother-Daughter Therapists Focus on BIPOC, LGBTQ Communities

For the owners of Magnolia Wellness, LLC, mental health is more than just a brain issue. Rather, say Gizelle Tircuit and her daughter Janelle Posey-Green, emotional wellness goes far beyond what’s inside someone’s head, encompassing their body, their community, their culture and more.

FindCenter AddIcon
FindCenter Post-Image

DSM-V: Interview With Social Worker Joanne Cacciatore, PhD, FT

I believe that social workers need to focus on that which we are trained to do: extend civic love and compassion to the client, staring where he or she is. We are not wed to the medical model; social work is ecological, psychosocial, and systems oriented.

FindCenter AddIcon
FindCenter Post-Image

Psychedelic Drugs Can Help Treat PTSD Caused by Racism, Discrimination: Researchers

Williams is the co-lead author of a recent retrospective study that found those who tried doses of psilocybin (more commonly known as magic mushrooms), LSD, or MDMA (the pure substance found in Ecstasy or Molly) reported a decrease in trauma symptoms, depression and anxiety after 30 days.

FindCenter AddIcon

EXPLORE TOPIC

DMT